HUP0303261A3 - Carbamate compounds for use in preventing or treating bipolar disorder - Google Patents

Carbamate compounds for use in preventing or treating bipolar disorder

Info

Publication number
HUP0303261A3
HUP0303261A3 HU0303261A HUP0303261A HUP0303261A3 HU P0303261 A3 HUP0303261 A3 HU P0303261A3 HU 0303261 A HU0303261 A HU 0303261A HU P0303261 A HUP0303261 A HU P0303261A HU P0303261 A3 HUP0303261 A3 HU P0303261A3
Authority
HU
Hungary
Prior art keywords
preventing
bipolar disorder
carbamate compounds
treating bipolar
treating
Prior art date
Application number
HU0303261A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of HUP0303261A2 publication Critical patent/HUP0303261A2/hu
Publication of HUP0303261A3 publication Critical patent/HUP0303261A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0303261A 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder HUP0303261A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168001P 2001-02-27 2001-02-27
US10/081,606 US7122576B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder
PCT/US2002/005425 WO2002067924A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (2)

Publication Number Publication Date
HUP0303261A2 HUP0303261A2 (hu) 2004-01-28
HUP0303261A3 true HUP0303261A3 (en) 2012-07-30

Family

ID=26765743

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303261A HUP0303261A3 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Country Status (25)

Country Link
US (1) US7122576B2 (cg-RX-API-DMAC7.html)
EP (1) EP1368021B1 (cg-RX-API-DMAC7.html)
JP (1) JP4276839B2 (cg-RX-API-DMAC7.html)
KR (1) KR20030074849A (cg-RX-API-DMAC7.html)
CN (1) CN1250214C (cg-RX-API-DMAC7.html)
AT (1) ATE378046T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002242226B2 (cg-RX-API-DMAC7.html)
BR (1) BR0207832A (cg-RX-API-DMAC7.html)
CA (1) CA2439292A1 (cg-RX-API-DMAC7.html)
CY (1) CY1107199T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ296641B6 (cg-RX-API-DMAC7.html)
DE (1) DE60223506T2 (cg-RX-API-DMAC7.html)
DK (1) DK1368021T3 (cg-RX-API-DMAC7.html)
ES (1) ES2295320T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0303261A3 (cg-RX-API-DMAC7.html)
IL (2) IL157589A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03007716A (cg-RX-API-DMAC7.html)
MY (1) MY133370A (cg-RX-API-DMAC7.html)
NO (1) NO20033799L (cg-RX-API-DMAC7.html)
NZ (1) NZ527989A (cg-RX-API-DMAC7.html)
PL (1) PL364640A1 (cg-RX-API-DMAC7.html)
PT (1) PT1368021E (cg-RX-API-DMAC7.html)
RS (1) RS50680B (cg-RX-API-DMAC7.html)
RU (1) RU2286147C2 (cg-RX-API-DMAC7.html)
WO (1) WO2002067924A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ553813A (en) * 2004-09-16 2010-09-30 Janssen Pharmaceutica Nv Use of 2-phenyl-1, 2-ethanediol-(DI) carbamates for treating epileptogenesis and epilepsy
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
EP1928451B1 (en) * 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
BRPI0718324A2 (pt) * 2006-10-30 2013-11-26 Sk Holdings Métodos para o tratamento de depressão.
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
HUP0700370A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
JP4409630B2 (ja) * 2008-02-21 2010-02-03 田辺三菱製薬株式会社 経口投与用固形製剤
HRP20150196T1 (hr) 2008-07-16 2015-06-05 Richter Gedeon Nyrt. Farmaceutske formulacije s ligandima receptora dopamina
HU230067B1 (hu) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
KR102635938B1 (ko) * 2016-12-14 2024-02-13 에스케이바이오팜 주식회사 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
CZ20032312A3 (cs) 2004-06-16
YU68003A (sh) 2006-08-17
RS50680B (sr) 2010-06-30
EP1368021A1 (en) 2003-12-10
CN1503666A (zh) 2004-06-09
NO20033799L (no) 2003-09-10
JP4276839B2 (ja) 2009-06-10
ATE378046T1 (de) 2007-11-15
WO2002067924A1 (en) 2002-09-06
CN1250214C (zh) 2006-04-12
ES2295320T3 (es) 2008-04-16
PT1368021E (pt) 2007-12-19
DE60223506D1 (de) 2007-12-27
CY1107199T1 (el) 2012-11-21
RU2286147C2 (ru) 2006-10-27
DE60223506T2 (de) 2008-09-18
HK1058762A1 (en) 2004-06-04
US20020193433A1 (en) 2002-12-19
BR0207832A (pt) 2004-06-22
DK1368021T3 (da) 2008-02-11
MXPA03007716A (es) 2004-11-12
IL157589A0 (en) 2004-03-28
KR20030074849A (ko) 2003-09-19
RU2003128996A (ru) 2005-03-10
AU2002242226B2 (en) 2006-06-29
HUP0303261A2 (hu) 2004-01-28
CA2439292A1 (en) 2002-09-06
IL157589A (en) 2009-09-22
NZ527989A (en) 2005-12-23
PL364640A1 (en) 2004-12-13
CZ296641B6 (cs) 2006-05-17
US7122576B2 (en) 2006-10-17
JP2004525905A (ja) 2004-08-26
MY133370A (en) 2007-11-30
NO20033799D0 (no) 2003-08-26
EP1368021B1 (en) 2007-11-14

Similar Documents

Publication Publication Date Title
ZA200503967B (en) Agent for preventing or treating neuropathy
HUP0501116A3 (en) Oxynthomodulin for preventing or treating excess weight
PT2311466E (pt) Compostos antimicrobianos e métodos para a sua utilização
AU6048201A (en) Quinazoline derivatives for the treatment of tumours
GB0113751D0 (en) Surface treatment
HUP0303261A3 (en) Carbamate compounds for use in preventing or treating bipolar disorder
EG23292A (en) Textile finishing composition and methods for using same.
IL157592A0 (en) Carbamate compounds for use in preventing or treating movement disorders
IL157591A0 (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
PL368556A1 (en) Methods for treating or preventing skin disorders using cd2-binding agents
HUP0303243A3 (en) Carbamate compounds for use in preventing and treating bipolar disorder
ZA200307475B (en) Carbamate compounds for use in the treatment of pain.
IL157588A0 (en) Carbamate compounds for use in preventing or treating psychotic disorders
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
GB2386602B (en) Anti-loading treatments
AU2002349788A8 (en) Fiber treatment agent composition
TWI318876B (en) Carbamate compounds for use in preventing or treating bipolar disorder
AU2002328383A1 (en) Equipment for treating painful points in the organism
ZA200307471B (en) Carbamate compounds for use in preventing or treating bipolar disorder.
PL1867644T3 (pl) Związki heteroarylo-tetrahydropiperydylowe przydatne w leczeniu lub zapobieganiu bólu
ZA200307477B (en) Carbamate compounds for use in preventing or treating movement disorders.
IL159846A0 (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
ZA200307473B (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders.
ZA200604723B (en) Agents for preventing and/or treating higher brain dysfunctions
GB0130694D0 (en) Treatment

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees